key: cord-0002337-qzrvvwhy
authors: Xue, Ruiqi; Gu, Huan; Qiu, Yamei; Guo, Yong; Korteweg, Christine; Huang, Jin; Gu, Jiang
title: Expression of Cystic Fibrosis Transmembrane Conductance Regulator in Ganglia of Human Gastrointestinal Tract
date: 2016-08-05
journal: Sci Rep
DOI: 10.1038/srep30926
sha: 9a13ccd6be3536af404c25e748c34eac997c5d16
doc_id: 2337
cord_uid: qzrvvwhy

CF is caused by mutations of the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) which is an anion selective transmembrane ion channel that mainly regulates chloride transport, expressed in the epithelia of various organs. Recently, we have demonstrated CFTR expression in the brain, the spinal cord and the sympathetic ganglia. This study aims to investigate the expression and distribution of CFTR in the ganglia of the human gastrointestinal tract. Fresh tissue and formalin-fixed paraffin-embedded normal gastrointestinal tract samples were collected from eleven surgical patients and five autopsy cases. Immunohistochemistry, in situ hybridization, laser-assisted microdissection and nested reverse transcriptase polymerase chain reaction were performed. Expression of CFTR protein and mRNA was detected in neurons of the ganglia of all segments of the human gastrointestinal tract examined, including the stomach, duodenum, jejunum, ileum, cecum, appendix, colon and rectum. The extensive expression of CFTR in the enteric ganglia suggests that CFTR may play a role in the physiology of the innervation of the gastro-intestinal tract. The presence of dysfunctional CFTRs in enteric ganglia could, to a certain extent, explain the gastrointestinal symptoms frequently experienced by CF patients.

Scientific RepoRts | 6:30926 | DOI: 10.1038/srep30926 CF patients may suffer from various gastrointestinal tract diseases, including the distal intestinal obstruction syndrome, meconium ileus of the newborn, intussusceptions, small bowel bacterial overgrowth, rectal prolapse, gastroparesis and gastroesophageal reflux 11, 23, 24 . The majority of these diseases are is causally related to the malfunction of the CFTR protein in the epithelial cells of the gastrointestinal tract and pancreas resulting in enzyme insufficiency and thickening of gastrointestinal secretions [25] [26] [27] [28] . However, given its crucial role in the control of motility, and exocrine and endocrine secretions in the tractus gastrointestionalis, it is conceivable that abnormalities in the ENS might also contribute to the pathogenesis of the gastrointestinal diseases found in CF. In this study, we aimed to investigate the distribution and expression of CFTR protein and mRNA in ganglion cells of the human ENS. Widespread expression of CFTR was demonstrated in the ENS, which could provide an additional explanation for the gastrointestinal symptoms in CF.

Human Tissue Collection. Human tissue samples of gastrointestinal tracts were obtained from a total of 16 patients, 11 from patients undergoing surgery and 5 autopsy cases from the Peking University Third Hospital (Beijing, PR China) and Shantou Medical University Hospital (Shantou, PR China). None of the subjects was diagnosed with any disease of the nervous system or CF. All methods were carried out in accordance with the approved guidelines of the Institutional Animal Care and Use Committee Guide of Peking University. All experimental protocols were approved by Peking University. The study received local hospital ethics committee approval. Informed consent was obtained from all patients. General information about these cases is listed in Table 1 .

Tissue Preparation. The autopsied bodies were kept at 4 °C, and the autopsies were performed within 48 hours after death. For immunohistochemistry and in situ hybridization, samples were fixed in 4% formalin solution after removal for 24 hours and then embedded in paraffin blocks. For reverse transcription-polymerase chain reaction (RT-PCR), fresh tissue samples were immediately snap-frozen in liquid nitrogen and stored at − 80 °C until use. The segments evaluated in this study include the stomach, duodenum, jejunum, ileum, cecum, appendix, colon and rectum. In each surgical case, the appropriate consent for the use of tissues was obtained. Samples were taken from macroscopically unaffected areas that were determined by visual inspection. Immunohistochemistry localization. CFTR expression was localized, using immunohistochemistry on consecutive formalin-fixed paraffin-embedded tissue sections (4 μm) which preserve good morphology for neuron identification and CFTR protein expression as following: (1) The tissue sections were deparaffinized in xylene and rehydrated in gradient ethanol, incubated in 70% ammonia-ethanol at room temperature for 30 min to remove formalin deposition and then washed in 0.01 M phosphate-buffered saline (PBS). (2) Antigen retrieval was performed by heating the slides at 96 °C in a sodium citrate buffer (pH 6.0) for 15 min 29 .

(3) After cooling to room temperature, slides were rinsed in 0.01 M PBS, then again in 3% hydrogen peroxide incubation for 30 min to quench the endogenous peroxidase activity. They were then washed with 0.01 M PBS 3 times for 3 min each. (4) Primary mouse anti-human monoclonal antibodies to CFTR (1:100; Zymed Laboratories, South San Francisco, CA, USA) and neurofilament (NF, 1:100; Dako, Copenhagen, Denmark) were added to 2 consecutive sections to identify CFTR-positive cells and ganglion cells, respectively, and incubated overnight at 4 °C. PBS was used in place of the primary antibody for the negative control sections. (5) Horseradish-peroxidase-conjugated anti-mouse/rabbit IgG (PV9000 immunohistochemistry kit; Zymed Laboratories) and horseradish-peroxidase conjugated anti-goat IgG (1:1000; Jackson, West Grove, PA, USA) were added and incubated at room temperature for 20 min as the secondary antibody. (6) After being washed in PBS, 3,3′ -diaminobenzidine (DAB; Zymed Laboratories) was used to visualize antigen localization. All slides were counterstained with hematoxylin. The results of immune staining on neurofilament (NF) on adjacent sections were compared to examine whether the CFTR-containing cells were neurons.

Laser-assisted microdissection, RNA extraction and nested RT-PCR. Because of the strong positive expression of CFTR in gastrointestinal tract epithelial cells, we performed a laser-assisted microdissection (LMD) to ensure the isolation of only gastrointestinal ganglion cells for RNA extraction followed by nested RT-PCR, to avoid possible contamination of nearby epithelial cells. The frozen tissue samples of human gastrointestinal tract segments were sectioned (10 μm) and mounted on pretreated slides (LCM DNase-free, RNase-free, PEN-membrane slides, Leica Microsystems, Wetzlar, Germany). The slides were then quickly fixed in 70% ethanol for 1 min, rinsed in DEPC-treated water for 30 s, stained with DEPC-treated hematoxylin for 1 min, and rinsed in DEPC-treated water (pH 8.0) twice for 30 s each time. All of the chemicals were prepared with DEPC-treated water. The ganglion cell groups were identified by their morphology, and were isolated from the frozen tissue sections using the Leica Microdissection System (Leica LMD 6000 B, Leica Microsystems). The microdissected target ganglia were then collected in an Eppendorf tube. Smooth muscle cell groups were captured and used to exclude the expression of CFTR in smooth muscle cells. Epithelial cell groups were also captured and used as positive controls. The procedure was performed in accordance with the manufacturer's instructions. RNA extraction was performed using the RNeasy Micro Kit (Qiagen, Cologne, Germany) to extract total RNA from the dissected ganglion cells. The reverse transcription was carried out with the Super Script III cDNA Kit (Invitrogen, CA, USA) following the manufacturer's instructions. Briefly, 5 μg of total RNA was extracted from the dissected tissue and reverse transcription reactions were performed using random primers at 55 °C for 60 min.

The sequences of the CFTR primers were obtained from the GenBank (acc. No. NM-031506). Nested RT-PCR was used to ensure the specificity of the results as two pairs of primers were employed. The primers for nested PCR were as follows: external 5′ -CACTGCTGGTATGCTCTCCA-3′ (sense), and 5′ -AATGAATGGCATCGAAGAGG-3′ (antisense); internal 5′ -CACTGCTGGTATGCTCTCCA-3′ (sense), and 5′ -ACCGAAAGACAACAGCATCC-3′ (antisense). The PCR products span one intron. 18S was amplified as an endogenous reference with the following primers: 5′ -AAACGGCTACCACATCCAAG-3′ (sense), and 5′ -CCTCCAATGGATCCTCGTTA-3′ (anti-sense). The final amplifying products of CFTR and 18S were 179 bp and 155 bp. Nested PCR was performed with Taq Polymerase (NEB, Nebraska, US). The first amplification with the external primers proceeded for 40 cycles of 30 s at 94 °C, 40 cycles of 30 s at 55 °C, and 40 cycles of 1 min at 72 °C. The final cycle was followed by an extension period of 10 min at 72 °C. The second amplification round with the internal primers proceeded in a manner identical to the first amplification round.

Plasmid construction, sequence analysis and cRNA probe preparation. To perform sequence analysis and generate the cRNA probe, we used a specifically designed CFTR RT-PCR product, as described before 17, 18, 30 . Human brain tissue RNA extraction was carried out using oligo (dT) primers by a cDNA synthesis kit (#K1621, Fermentas; Lithuania). The PCR was then performed with pairs of specific primers for nested RT-PCR. They were encoded as follows: 5′ -CCCTTCGGCGATGTT-3′ , 5′ -CAGGAAACCAAGTCCACAG-3′ (external); and 5′ -AGGAGGAACGCTCTATCG-3′ , 5′ -GCAGACGCCTGTAACAAC-3′ (internal). The final amplification product of CFTR was 328 bp and encompassed two splicing events. The first amplification of PCR was performed for 40 cycles of 1 min at 94 °C, 40 cycles of 30 s at 72 °C, and 40 cycles of 30 s at 52 °C; the second amplification round was for 40 cycles of 1 min at 94 °C, 40 cycles of 30 s at 72 °C, and 40 cycles of 30 s at 54 °C. In both reactions, the first PCR cycle was preceded by an incubation period of 10 min at 94 °C, and the final cycle was followed by an extension period of 5 min at 72 °C. Five μg of the product was separated on 2% agarose gel by electrophoresis, extracted from the gel using the Gel DNA Extraction kit (Tiangen Biotech, Beijing, China), and then subcloned into the pGM-T vector by T4 ligase (Tiangen Biotech). The plasmid was then transfected into Escherichia coli XLl-Blue. X-gal/ isopropyl-b-D-thiogalactopyranoside and ampicillin (100 μg/mL) double selections were performed.

Sequencing was carried out to determine the identity of the CFTR gene. Plasmid, extracted from the positive clone, was linearized with either the SalI or NcoI restriction enzyme, and an in vitro transcription reaction was performed to generate the cRNA probe. Anti-sense cRNA probes were generated with Sp6 RNA polymerase, and sense probes were generated with T7 RNA polymerase. The probes were labeled with a Digoxigenin RNA Labeling Mix (Roche Molecular Biochemicals; Mannheim, Germany) for in situ hybridization.

In situ hybridization localization. To determine the CFTR mRNA localization in human gastrointestinal ganglia, we performed in situ hybridization on consecutive formalin-fixed paraffin-embedded tissue sections (4 μm) with a specific cRNA anti-sense probe against the CFTR gene prepared as described above. All the solutions used were prepared with diethyl-pyrocarbonate (DEPC)-treated water to avoid mRNA degradation. The tissue sections were deparaffinized in xylene, rehydrated in gradient ethanol, incubated in 1 N HCl at room temperature for 10 min to increase permeability and washed in 0.01 M phosphate-buffered saline (PBS). The slides were heated to 96 °C in sodium citrate buffer (pH 6.0) for 15 min 29 . After being cooled to room temperature, and rinsed in 0.01 M PBS, the slides were fixed in 4% paraformaldehyde for 10 min, washed and dehydrated in 90% ethanol for 15 s, and hybridized overnight at 45 °C with the specific digoxigenin-labeled CFTR cRNA probe. The slides were then washed three times, first with 2× standard saline citrate (SSC) plus 50% formamid, then with 2× SSC, and finally with 0.1× SSC at 37 °C for 15 min each. After blocking with normal horse serum (1:100) at room temperature for 1 hour, the sections were incubated with an alkaline phosphatase-labeled anti-digoxigenin antibody (1:500; Roche Diagnostics, Pensberg, Germany) for 1 hour. Nitro blue tetrazolium/5-bromo-4-choloro-3-indolyl phosphate (NBT/BCIP; Promega Corp., Madison, Wis.) was used to visualize the reaction staining, which resulted in a purple-blue signal. All slides were counterstained with methyl green. The slides were incubated with a corresponding sense probe or with hybridizing solutions only as negative controls. To identify the cell type that expressed CFTR mRNA, immunostaining with antibody to NF was performed on tissue sections consecutive to the ones on which CFTR in situ hybridization staining was performed. The NF immunostaining results were compared with the CFTR in situ hybridization results on consecutive sections to investigate whether CFTR mRNA positive cells were NF-positive neurons.

The human enteric ganglia were identified based on their location and morphology. They were composed of small cell groups of enteric neurons, glial cells and nerve fibers. The number, shape, size and orientation of the neurons in each ganglion varied in the different gastrointestinal segments.

CFTR immunoreactivity was detected in the cytoplasm and dendrites of all neurons of the human enteric ganglia by IHC, both in myenteric and submucosal plexus. Consecutive sections showed the presence of positive NF (neurofilament, specific neuronal cell marker) IHC signal in all CFTR-positive cells. The smooth muscle cells and glial cells showed negative immunostaining for CFTR and NF. The specificity of IHC was established in parallel control experiments. In the positive control, strong CFTR-positive signals were detected in human gastric epithelium. In the negative controls, no specific signal was observed. In all segments of the tractus gastrointestinalis, the expression and distribution of CFTR were similar (Fig. 1) . No obvious differences were observed either among the different segments of the gastrointestinal tract of each case, or among the different cases.

CFTR mRNA expression in human gastrointestinal ganglia by ISH. CFTR mRNA expression was detected and localized by in situ hybridization. Positive CFTR mRNA anti-sense signals were found in the cytoplasm and dendrites of all neurons of the enteric ganglia. Positive signals were detected in all of the gastrointestinal segments examined. The distribution pattern was identical to that of CFTR protein as detected by IHC. In some cases nuclei also showed positive hybridization signals. No signal was observed in either smooth muscle cells or glial cells. IHC with antibody to NF on consecutive sections confirmed that the CFTR mRNA positive cells were indeed neurons. In gastric epithelium, which was used as positive control, strong CFTR mRNA signals were detected. In the negative controls, no specific signal was observed when the specific probe was replaced by the CFTR sense probe or hybridization solution. The expression and distribution of CFTR mRNA displayed the same pattern among the various segments of the gastrointestinal tracts studied (Fig. 1 ).

As CFTR is known to be extensively expressed in the epithelium throughout the gastrointestinal tract, we performed LMD to carefully isolate enteric ganglia without epithelial cells (Fig. 2) . Following isolation of the ganglion cells, nested RT-PCR was performed. The CFTR product of 179 bp was identified by agarose gel electrophoresis (Fig. 2 ). In addition, NF mRNA was successfully amplified confirming that ganglionic neurons had indeed been captured by LMD, whereas lack of CK mRNA amplification indicated that solely ganglion cells had been isolated.

Smooth muscle cells were captured to exclude the expression of CFTR and showed a much weaker positive PCR product. Colon epithelial tissue was used as positive control and showed a PCR product of the expected size. In the negative control no amplification signal was detected. Sequence analysis was in 100% agreement with the human CFTR mRNA sequence as encoded by the NCBI.

In this study we demonstrated CFTR expression in human enteric ganglia, which could offer a better understanding of the functions of CFTR in the normal physiology of the ENS, as well as in CF patients.

Originally the epithelial cell was regarded as the only cell type expressing CFTR. The CFTR gene with its gene product was identified in 1989 and its expression was detected in the epithelial cells of those organs most severely affected in CF, including the lungs, intestines, kidney, pancreas and liver 25, [31] [32] [33] . In the tractus gastrointestinalis CFTR was found localized to the mucosal epithelial cells of the stomach, duodenum, jejunum, ileum and colon, with crypt cells expressing more CFTR than villus cells 34, 35 . However, in the years following the discovery of CFTR several other cell types were found to express CFTR, such as fibroblasts, neutrophils, lymphocytes, macrophages, and mast cells 36, 37 . In respect to the human nervous system, CFTR expression was detected in the hypothalamus 15 . Yet recent studies have demonstrated a more widespread expression of CFTR in both the central and peripheral nervous system, including various regions of the brain, as well as spinal, cerebellum, sympathetic ganglia, paracervical ganglia and trigeminal ganglion 17 patients with CF might be directly related to the loss of CFTR 40 . In the present study we investigated CFTR expression in the ganglia of the ENS in various segments of the human gastrointestinal tract, including the stomach, duodenum, jejunum, ileum, cecum, appendix, colon and rectum. The results of IHC, ISH and RT-PCR, all convincingly demonstrate the presence of CFTR mRNA and protein in both the myenteric and submucosal plexuses. Immunohistochemistry with antibodies to CFTR and NF and in situ hybridization with a CFTR mRNA anti-sense probe on consecutive sections demonstrated that the cells expressing CFTR were NF-positive neurons. As the enteric ganglia are in close proximity to the mucosal epithelial cells, which abundantly express CFTR, LMD was performed prior to RT-PCR to isolate only neurons. Successful amplification of NF mRNA and lack of amplification of CK mRNA confirmed that neurons were captured, but not epithelial cells.

The extensive expression of CFTR in both the central nervous system and the peripheral nervous system including the ENS suggests that this protein may play a role in the normal functioning of the nervous system. CFTR might be involved in neuronal physiology through several mechanisms, as discussed previously by Guo et al. 17, 18 , with the most important ones being the following: maintenance of the steady-state of intracellular electrolytes 41 , regulation of membrane recycling [42] [43] [44] [45] [46] [47] , modulation of membrane traffic 48, 49 , governing the efflux of gluthatione 50, 51 , regulation of neuropeptide secretion 15 , and functioning as a neuromodulator and cell signaling molecule. Consequently, mutation of CFTR could theoretically lead to neuronal dysfunctioning.

The ENS constitutes together with the parasympathetic and sympathetic nervous systems the autonomous nervous system. Autonomous neuropathy appears to exist in patients with CF 52 , as illustrated by decreased cardiovascular sensitivity to β -adrenergic stimulation 12, 53 and abnormal α -adrenergic and cholinergic regulation of the pupils 53, 54 . Whether autonomic dysfunction of the gastrointestinal tract frequently occurs in CF patients is not clear, as symptoms might be non-specific and accurate tests to determine abnormalities are not readily available 52 . The main etiological factors of autonomic neuropathy in CF are considered to be metabolic and nutritional 52 . Given the expression of CFTR in the ENS together with the previously established CFTR expression in the sympathetic ganglia and paracervical ganglia, it is conceivable that malfunction of CFTR in the ganglionic neurons also contributes to the occurrence of autonomic neuropathy in CF.

Gastrointestinal manifestations are frequently observed in CF patients and include delayed gastric emptying, gastritis, distal intestinal obstruction syndrome, meconium ileus of the newborn, intussusceptions, fibrosing colonopathy, and rectal prolapse, among others 8, 10, 11, 23, 24, 28, [55] [56] [57] . Some of these manifestations have a direct causal relation to the malfunction of the CFTR in epithelial cells of gastrointestinal tract and pancreas, such as the distal intestinal obstruction syndrome and meconium ileus, whereas others, such as fibrosing colonopathy and gastritis, are regarded as secondary complications of the disease or its therapy 24 . As CFTR is responsible for anion transport 58, 59 , its dysfunction causes abnormal water and electrolyte secretion resulting not only in thick and adherent fluids in the intestines but also in the development of mucous and acidic enzyme secretions in the pancreas causing destruction of pancreatic tissue with ensuing exocrine pancreatic insufficiency leading on its turn to malabsorption in the gastrointestinal tract 57, 60 . In light of the regulatory role of the ENS in motility, water and electrolyte flow and endocrine secretions in the gastrointestinal tract 21 , it appears, however, not unlikely that ENS abnormalities caused by dysfunctional CFTR may also play a role in the pathogenesis of gastrointestinal diseases in CF.

In this context, it is of interest to note that immaturity of the myenteric plexus appeared to be the main etiological factor in newborns with meconium ileus without CF 61, 62 . In addition, myenteric ganglionitis, aganglionosis, and neuronal dysplasia have all been found in CF patients with distal intestinal obstruction syndrome and meconium ileus [63] [64] [65] . These findings support the assumption that abnormalities of enteric ganglia might induce dysfunction of the gastrointestinal tract.

In conclusion, our study provides evidence of CFTR expression in the neurons of the ENS. Widespread distribution of CFTR in enteric ganglia throughout the gastrointestinal tract suggests that this protein might exert a role in maintaining the normal structure and physiological functions of enteric ganglion cells. In addition, the presence of dysfunctional CFTR in the ENS may have adverse effects on the gastrointestinal tract. Further research is required to clarify the exact function of CFTR in the ENS and the implications of dysfunctional CFTR in the enteric ganglia for patients with CF.

CFTR localization in native airway cells and cell lines expressing wild-type or F508del-CFTR by a panel of different antibodies

Regulation of airway surface liquid volume by human airway epithelia

CFTR channels in immortalized human airway cells

Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening

CFTR channel insertion to the apical surface in rat duodenal villus epithelial cells is upregulated by VIP in vivo

Morphological changes in the vas deferens and expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in control, deltaF508 and knock-out CFTR mice during postnatal life

Early pulmonary inflammation in infants with cystic fibrosis

Airway mucus in cystic fibrosis

Abdominal manifestations of cystic fibrosis in adults: a review

Abdominal manifestations of cystic fibrosis in children

Acquired segmental megacolon in an adult patient with cystic fibrosis

Polymorphic expression of multidrug resistance mRNA in lung parenchyma of nonpregnant and pregnant rats: a comparison to cystic fibrosis mRNA expression

Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain

Cystic fibrosis transmembrane conductance regulator expression in human hypothalamus

Cystic fibrosis transmembrane conductance regulator protein expression in brain

Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the human brain

Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the spinal cord

Cystic fibrosis mRNA expression in rat brain: cerebral cortex and medial preoptic area

Expression of cystic fibrosis transmembrane conductance regulator in paracervical ganglia

The enteric nervous system

Muscle innervation of the gut: structure and pathology

Patterns of GI disease in adulthood associated with mutations in the CFTR gene

Abdominal manifestations of cystic fibrosis in older children and adults

Cystic fibrosis: a current review

Cystic fibrosis in children and young adults: findings on routine abdominal sonography

Pathology of gastrointestinal organs in a porcine model of cystic fibrosis

Gastrointestinal manifestations of cystic fibrosis: a review

Molecular pathology in the lungs of severe acute respiratory syndrome patients

Expression of cystic fibrosis transmembrane conductance regulator in ganglion cells of the hearts

Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia

Functional expression and apical localization of the cystic fibrosis transmembrane conductance regulator in MDCK I cells

Physiological basis of cystic fibrosis: a historical perspective

Immunocytochemical localization of the cystic fibrosis gene product CFTR

Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization

Expression and functional characterization of CFTR in mast cells

Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin

Cystic fibrosis transmembrane conductance regulator expression in human spinal and sympathetic ganglia

Cystic fibrosis transmembrane conductance regulator modulates neurosecretory function in pulmonary neuroendocrine cell-related tumor cell line models

CFTR-deficient pigs display peripheral nervous system defects at birth

Defective regulation of outwardly rectifying Cl-channels by protein kinase A corrected by insertion of CFTR

Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications

Intracellular CFTR: localization and function

Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis

The outcome of 72 pregnancies in 55 women with cystic fibrosis in the United Kingdom

Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator

Insulin resistance is associated with decreased clinical status in cystic fibrosis

Mechanisms of CFTR regulation by syntaxin 1A and PKA

The biogenesis, traffic, and function of the cystic fibrosis transmembrane conductance regulator

Potential for antioxidant therapy of cystic fibrosis

CFTR directly mediates nucleotide-regulated glutathione flux

Autonomic dysfunction in cystic fibrosis

Abnormal adrenergic and cholinergic sensitivity in cystic fibrosis

Pupillary dysfunction as a concomitant of cystic fibrosis

Delayed gastric emptying scintigraphy in cystic fibrosis patients before and after lung transplantation

Distal intestinal obstruction syndrome in adults with cystic fibrosis

Pathology of pancreatic and intestinal disorders in cystic fibrosis

Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia

Mechanosensitive gating of CFTR

Pathophysiology of the exocrine pancreas in cystic fibrosis

Neonatal functional intestinal obstruction and the presence of severely immature ganglion cells on rectal biopsy: 6 year experience

Immaturity of the myenteric plexus is the aetiology of meconium ileus without mucoviscidosis: a histopathologic study

Another case of cystic fibrosis complicated by meconium ileus associated with Hirschsprung's disease: a rare and important association

Lymphocytic leiomyositis and myenteric ganglionitis are intrinsic features of cystic fibrosis: studies in distal intestinal obstruction syndrome and meconium ileus

Intestinal neuronal dysplasia associated with cystic fibrosis

This work was supported by grants from the Li Kashing Foundation and the National Natural Science Foundation of China to JG No. 81030033, 30971150, 81001199 and No. 30950110335. We would like to thank Reproductive Center of First Affiliated Hospital of Shantou University Medical College for their kind helps. 

Competing financial interests: The authors declare no competing financial interests.